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Invariant NKT Cells Suppress CD8þ T-Cell–Mediated
Allergic Contact Dermatitis Independently of
Regulatory CD4þ T Cells
Anne Goubier1,2,3,6, Marc Vocanson1,2,3,6, Claire Macari1,2,3, Gaelle Poyet1,2,3, Andre´ Herbelin4,5,
Jean- Franc¸ois Nicolas1,2,3, Bertrand Dubois1,2,3,6 and Dominique Kaiserlian1,2,3,6
Invariant natural killer T (iNKT) cells expressing a CD1d-restricted invariant abTCR have key regulatory roles in
autoimmunity, pathogen immunity, and tumor surveillance, but their function in the control of allergic skin
diseases remains poorly documented. Using a model of contact hypersensitivity (CHS) to the hapten DNFB, we
show here that iNKT cell deficiency results in enhanced skin inflammation due to augmented hapten-specific
IFN-g-producing CD8þ effectors in skin draining lymph nodes (dLNs) and their massive recruitment into the
allergen-exposed skin. Adoptive transfer and antibody depletion experiments as well as in vitro studies revealed
that iNKT cells (1) reduce the severity of CHS, even in presensitized mice, (2) require hapten presentation by
CD1dþ dendritic cells (DCs) to dampen skin inflammation, and (3) produce IL-4 and IL-13 after CD1d-dependent
in vitro stimulation by hapten-loaded DCs only in the presence of IFN-g released from activated CD8þ effector
T cells. In corollary, mice double deficient in IL-4 and IL-13 exhibit an exacerbated CHS. Finally, iNKT-suppressive
function is independent of Foxp3þ regulatory T cells (Tregs). These data highlight that, besides Foxp3þ Tregs,
iNKT cells are potent downregulators of CD8þ T cell–mediated CHS, and underscore that both cell types are
important for the regulation of allergic skin inflammation.
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INTRODUCTION
Invariant natural killer T (iNKT) cells are a distinct lineage of T
cells that coexpress invariant TCRa chains (Va14Ja18 in mice
and Va24Ja18 in humans) and natural killer receptors, and
that are reactive to lipids/glycolipids presented by the major
histocompatibility complex class I–like molecule, CD1d.
Another class of lipid/CD1d-restricted T cells, referred to as
variant NKT or type-II NKT cells, express variable (noninvar-
iant) TCRs (Godfrey and Berzins, 2007). Mouse invariant NKT
(iNKT) cells constitute up to 30–40% of TCRabþ T cells in the
liver. They recognize glycolipids presented by CD1d
expressed by various types of dendritic cells (DCs), including
dermal DCs (Gerlini et al., 2001) and epidermal Langerhans
cells (Fukunaga et al., 2010). CD1d ligands activating iNKT
cells include synthetic a-galactosylceramide (a-GalCer),
microbial lipids, and endogenous ligands (Bendelac et al.,
2007). a-GalCer stimulation of iNKT cells induces the release
of IFN-g and IL-4, which enhance the function of DCs and
T cells, linking innate and adaptive immunity (Bendelac et al.,
2007). Although iNKT cells can stimulate T-cell immunity to
pathogens and tumors (Bendelac et al., 2007), they can act as
regulatory cells in autoimmunity (Novak and Lehuen, 2011),
peripheral, and mucosal T-cell tolerance (Sonoda et al., 1999)
and tumor surveillance (Taniguchi et al., 2010). Such dual
functionality of iNKT cells has not been so far documented in
allergy. Indeed, iNKT cells were reported to promote airway
hyperreactivity by licensing Th2 (T helper type)-type cell entry
into the lung (Akbari et al., 2003; Lisbonne et al., 2003), to
mediate contact hypersensitivity (CHS) to picryl chloride
(Campos et al., 2003), and to infiltrate the inflamed skin of
patients with allergic contact dermatitis (Gober et al., 2008).
However, recent evidence that iNKT cells can dampen T-cell
responses to skin antigens (Fukunaga et al., 2010; Mattarollo
et al., 2011) suggests that they might also inhibit CHS
responses reproducing allergic contact dermatitis.
CHS is induced by epicutaneous challenge of mice,
topically presensitized to strong haptens such as DNFB, which
become immunogenic after covalent binding to self-proteins.
We and others have documented that CHS to DNFB is
mediated by allergen-specific class I–restricted CD8þ T cells
(Bour et al., 1995; Xu et al., 1996), which are primed in
skin draining lymph nodes (dLNs) and differentiate into
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IFN-g-producing cytolytic effectors (Kehren et al., 1999). After
skin challenge with the hapten, these effectors are recruited
into skin and initiate inflammation by inducing keratinocyte
apoptosis (Akiba et al., 2002). The intensity and resolution of
the CHS response is controlled by regulatory CD4þ T cells
(Tregs; Bour et al., 1995), notably CD4þCD25þFoxp3þ
ICOSþ Tregs (Dubois et al., 2003; Vocanson et al., 2010)
and hapten-induced Th2-type CD4þ T cells (Xu et al., 1996).
Here we show that iNKT cells represent a critical regulator of
CHS, which inhibits CD8þ T cell–mediated allergic skin
inflammation independently of CD4þ Tregs.
RESULTS
iNKT cells control both the afferent and efferent phases of CHS
We previously documented that the defects of CD4þCD25þ
Tregs in major histocompatibility complex class II–deficient
(Ab / ) mice resulted in enhanced CHS response to DNFB
(Bour et al., 1995; Dubois et al., 2003). In addition, depletion
of CD4þ T cells in Ab / mice further enhanced the CHS
response, pointing out to residual Tregs (Kish et al., 2007).
Because CD1d-restricted NKT cells account for most of the
residual CD4þ T cells in A / mice (Cardell et al., 1995),
and mAb depletion of NK1.1þ cells exaggerated their CHS
response to DNFB (data not shown), we examined the
regulatory potential of NKT cells on the CHS response.
CD1d-KO (CD1d / ) mice, deficient in all CD1d-restricted
NKT cells (Smiley et al., 1997), exhibited an enhanced CHS
response as compared with CD1dþ /þ littermates or syngeneic
wild-type (WT) mice (Figure 1a and b). Importantly, Ja18 /
mice, which specifically lack iNKT cells (Cui et al., 1997), also
exhibited an increased CHS (Figure 1c) that was not affected
by treatment with the anti-NK1.1 PK136 mAb (Figure 1d),
indicating that iNKT cells, but not NK cells, downregulate
CHS. Moreover, B6 mice injected with PK136, either before
DNFB sensitization to induce NKT cell depletion during both
afferent and efferent phases of CHS (Figure 1e) or before
DNFB challenge (Figure 1f), similarly displayed an increased
ear swelling response, indicating that iNKT cells might
negatively control both CD8þ T-cell priming during sensitiza-
tion and the reactivation of CD8 effectors during elicitation.
Lack of iNKT cells augments the priming of CD8 CHS effectors
Analysis of the hapten-specific CD8þ T-cell response in skin
dLNs after DNFB sensitization showed a similar enhancement
of hapten-specific proliferation (Figure 2a) and frequency of
IFN-g-producing CD8þ T cells (Figure 2b) in CD1d / and
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Figure 1. Contact hypersensitivity (CHS) to DNFB is downregulated by
invariant natural killer T (iNKT) cells. CHS to DNFB was tested in various
settings. (a, b) CHS response of CD1d / (black circle) compared with
CD1dþ /þ littermates (a, white circle) or B6 (b, white circle) mice. (c, d) CHS
response of Ja18 / mice (black circle) compared with B6 (c, white circle)
mice or Ja18 / mice treated on days 1, 0, þ 1, and þ 4 with the anti-
NK1.1 PK136 mAb (d, white circles). (e, f) CHS in B6 mice either untreated
(white circle) or injected with PK136 (black circle) on (e) days 3,  2, and
1 before sensitization or on (f) days þ 4, þ 5, and þ 6 after sensitization.
Results are expressed as the mean±SD ear swelling at different times after
challenge, and are representative of two independent experiments using five to
seven mice per group. *Po0.05, **Po0.01, Mann–Whitney U-test.
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Figure 2. Enhanced priming and skin recruitment of CD8 effectors in
CD1d / and Ja18 / mice. (a, b) Hapten-specific CD8þ T-cell response in
lymph nodes (LNs) of day 5 DNFB-sensitized C57BL/6 (white bars), CD1d /
(black bars), and Ja18 / (hatched bars) mice. (a) Hapten-specific
proliferation of CD8þ T cells (mean±SD of triplicate wells) measured by
tritiated thymidine (3H-TdR) uptake. (b) Frequency of hapten-specific IFN-g
spot forming cells (SFCs) in draining LNs (dLNs) determined by ELISPOT
(mean±SD SFC/106 CD8þ T cells of triplicate wells containing pooled CD8þ
T cells from four mice per group). (a, b) Data are representative of one out of
three experiments. (c) Number (No.) of CD8þ T cells in the ears of B6 (white
bars) and CD1d / (black bars) mice at 48 hours after DNFB challenge was
determined by FACS analysis. The results show mean±SD obtained using
three mice per group and are representative of one out of two experiments.
c.p.m., counts per minute.
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Ja18 / mice, compared with WT mice. FACS analysis
revealed a 4-fold increase of CD8þ T-cell numbers in
inflamed ears of CD1d / mice compared with B6 mice at
48 hours after challenge (Figure 2c). iNKT cells were virtually
undetectable up to day 4 after challenge, using mCD1d-a-
Galcer tetramers (data not shown). These data show that iNKT
cells downregulate the priming of hapten-specific CD8þ
T cells, resulting in lower numbers of CD8þ T-cell effectors
recruited into the challenged skin.
iNKT cell transfer normalizes CD8þ T cell–mediated CHS
response in Ja18 / mice
To further confirm the regulatory function of iNKT cells on
CHS, adoptive transfer experiments were carried out. Intrave-
nous injection of purified liver NKT cells into Ja18 / mice,
1 day before either hapten sensitization (Figure 3a) or hapten
challenge (Figure 3b), similarly decreased the frequency of
hapten-specific IFN-g-producing T cells in dLNs. Moreover,
transfer of total liver mononuclear cells, containing 25%
a-Galcer tetramerþ iNKT cells, into Ja18 / mice before
challenge restored a normal CHS response (Figure 3c),
whereas transfer of liver mononuclear cells from naive
Ja18 / mice (e.g., liver cells devoid of iNKT cells) did not
(data not shown). These data indicate that the adoptive transfer
of iNKT cells can normalize CHS in Ja18 / mice by
controlling both the priming and the reactivation of hapten-
specific CD8þ effectors.
iNKT cells control CHS independently of CD4þFoxP3þ Tregs
To analyze the interplay between iNKT cells and classical
CD4þCD25þFoxP3þ Tregs for the control of CHS, we
examined the impact of NKT cell deficiency on the number,
activation state, and functions of Tregs. B6, CD1d / , and
Ja18 / mice displayed comparable frequencies and num-
bers of CD8þ , CD4þ , and Foxp3þ cells in spleen and
LN (Figure 4a and data not shown), as well as similar
activation of CD4þCD25þFoxP3þ Tregs after DNFB sensiti-
zation (Figure 4b), as measured by the expression of ICOS
(Vocanson et al., 2010; Gomez de Aguero et al., 2012).
Moreover, reactivation of DNFB-specific Tregs, as assessed by
their capacity to proliferate in vivo in response to DNFB
sensitization (Vocanson et al., 2010), was observed in
Ja281 / mice and was not merely modified by adoptively
transferred NKT cells (Figure 4c). In addition, CD4þCD25þ
ICOSþ Tregs were recruited in similar numbers and
kinetics as in NKT-sufficient B6 mice (Figure 4d). Standard
in vitro antigen-specific suppressive assays (Vocanson et al.,
2010) further revealed that naive (or DNFB-induced, data
not shown) NKT cells did not improve the activity of
CD4þCD25þ Tregs isolated from either naive or DNFB-
sensitized mice (Figure 4e). These data provide compelling
evidence that NKT cells do not affect hapten-induced
Treg activation, expansion, or functions. Finally, the depletion
of CD4þ T cells exacerbated the CHS response similarly in
CD1d / , Ja18 / , (Figure 4f) and B6 mice (Bour et al.,
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Figure 3. Transfer of invariant natural killer T (iNKT) cells normalizes CD8þ
T-cell and contact hypersensitivity (CHS) responses in Ja18 / mice.
(a, b) Frequency of hapten-specific IFN-g spot forming cells (SFCs) in draining
lymph nodes (dLNs) at (a) day 5 after sensitization or (b) day 2 after challenge
in Ja18 / mice that were either untransferred (white bars) or transferred
(black bars) with purified liver naive iNKT cells 1 day before either (a)
sensitization or (b) challenge with DNFB. Data correspond to mean±SD
SFC/106 LN cells of triplicate wells containing pooled LN cells from four mice
per group, and are representative of one out of two experiments. (c) CHS to
DNFB in B6 (circles) and Ja18 / (triangles) mice either untransferred (white
symbols) or transferred 1 day before challenge (black symbols) with 4 106
liver B6 leukocytes. Each symbol represents the ear swelling of individual
mouse at 48 hours after challenge and horizontal bars indicate the mean±SD
of 5 mice per group. Data are representative of one out of two experiments.
*Po0.05, Mann–Whitney test. NS, nonsignificant.
Figure 4. Invariant natural killer T (iNKT) cells control the contact hypersensitivity (CHS) response independently of CD4þ regulatory T cells (Tregs).
(a) Number of splenic CD4þ , CD8þ , and FoxP3þ T cells in B6, Ja18 / , and CD1d / mice (mean±SEM, four mice per group). NS (nonsignificant),
Mann–Whitney test. (b) CD4þFoxP3þ inducible costimulatory molecule (ICOS)þTregs in draining lymph nodes (dLNs) of day 5 sensitized B6, Ja18 / , and
CD1d / mice. Horizontal bars show mean percentages of four mice (NS, Mann–Whitney test). (c) In vivo proliferation of carboxyfluorescein diacetate
succinimidyl ester (CFSE)þCD4þFoxP3þ Tregs from day 6 sensitized B6 mice, 3 days after transfer and sensitization in Ja18 / recipients (black dots) alone or
together with naive NKT cells. Gray dots represent endogenous cells. (d) Kinetics of post-challenged CD4þCD25þ ICOSþ Tregs infiltration in the ears of sensitized
B6 and CD1d / mice (mean±SEM, three mice per group). (e) Suppression of in vitro proliferation (measured by uptake of tritiated thymidine [3H-TdR])
of DNFB-specific CD8þ T cells (effector T-cell, Teff) by Tregs from DNFB-sensitized mice with or without naive NKT cells. (f) CHS in Ja18 / (circles) and
CD1d / (squares) mice treated (black symbols) or not (open symbols) with an anti-CD4 mAb. Each symbol represents the mean±SD of ear swelling values
from five to six mice (*Po0.05, **Po0.01, Mann–Whitney test). c.p.m., counts per minute.
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1995). Altogether, these results indicate that NKT cells operate
independently of classical CD4þFoxP3þ Tregs to control
CHS responses.
CD1d-deficient DCs exacerbate CHS to DNFB
To examine whether iNKT cell regulation of CHS required
interaction with CD1d expressed by DCs, CHS was induced by
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subcutaneous immunization with bone marrow–derived DCs
(BM-DCs) from WT or CD1d / mice. Mice immunized
with 2,4-dinitrobenzene-sulfonic acid (DNBS)-pulsed BM-DCs
developed a CHS response upon ear challenge with DNFB
(Figure 5), confirming our previous report (Krasteva et al.,
1998). Interestingly, similarly exacerbated CHS responses
were observed in B6 mice immunized with DNBS-pulsed
CD1d / BM-DCs from CD1d / mice and in CD1d /
mice immunized with DNBS-pulsed BM-DCs from either B6 or
CD1d / mice. Thus, iNKT cells required CD1d-expressing
DCs during sensitization to regulate the CHS response.
IFN-c from CD8þ T-cell effectors triggers CD1d-dependent
secretion of IL-4 and IL-13 by iNKT cells
Because NKT cells can produce Th2-type cytokines, which
modulate CHS responses (Xu et al., 1996), we investigated
whether hapten-presenting DCs could trigger the production
of IL-4 and IL-13 by iNKT cells. Neither IL-4 nor IL-13 could
be detected in the supernatant of iNKT cells cocultured with
hapten-pulsed BM-DCs alone (Figure 6a). However, addition
of CD8þ T cells from DNFB-sensitized mice induced the
production of IL-4 and IL-13, but not IFN-g (data not shown).
Production of both cytokines was strongly reduced when
cocultures were performed (1) with CD1d-deficient BM-DCs,
(2) in the presence of anti-CD1d-neutralizing antibodies
(Figure 6a), or (3) with IL-4/IL-13-deficient iNKT cells
(Figure 6b), demonstrating that NKT cells were the source of
IL-4 and IL-13 and required CD1d expression on DCs to
secrete these cytokines. Interestingly, the production of both
cytokines by iNKT cells was blocked by the addition of an
anti-IFN-g mAb, and was undetectable in cocultures using
CD8 T cells from naive mice, even in the presence of
exogenous IFN-g (Figure 6c). Thus, these data demonstrate
that NK-T cells produce IL-4 and IL-13 in response to
stimulation through CD1d on DCs, provided that IFN-g is
secreted by specific CD8þ effector T cells.
Enhanced CHS to DNFB in IL-4/IL-13 double-deficient mice
On the basis of the above observations and the fact that iNKT
cells can rapidly produce large amounts of IL-4 and IL-13
upon activation in vivo (Akbari et al., 2003), we next asked
whether these cytokines contributed to the regulation of CHS.
Mice double deficient for IL-4 and IL-13 (IL-4 / /IL-13 / )
exhibited a significantly increased CHS response to DNFB
(Figure 6d). Alternatively, IL-4-deficient mice exhibited a CHS
response similar to that of WT B6 mice (data not shown), in
agreement with a previous report (Nagai et al., 2000). These
data indicated that IL-13, either alone or in synergy with IL-4,
can downregulate CHS to DNFB.
DISCUSSION
This study demonstrates that iNKT cells are important actors in the
control of CD8þ T-cell-mediated allergic contact dermatitis. We
showed that defects in iNKT cells in B6 mice, induced by genetic
disruption of either the CD1d molecule or the invariant Va14Ja18
TCR or by the depletion of NK1.1þ cells, exacerbated CHS to
DNFB because of the increased priming of hapten-specific IFN-g-
producing CD8þ T cells in LNs and their enhanced recruitment in
the challenged skin. Moreover, reconstitution of Ja18 / mice
with liver iNKT cells before either sensitization or challenge
decreased IFN-g-producing CD8þ T cells in skin dLNs and
normalized the CHS response. This demonstrates that iNKT cells
control both afferent and efferent phases of DNFB-specific CHS.
Our data corroborate recent studies reporting that iNKT
cells inhibit CD8þ T-cell responses in mice in the context of
skin graft (Mattarollo et al., 2011) and in virally induced type 1
diabetes (Diana et al., 2011). However, they apparently
contrast with previous studies from the group of Askenase,
showing a critical inductive role of iNKT cells in CHS. Indeed,
in BALB/c mice, sensitization with Picryl chloride (Campos
et al., 2003) or DNFB (Askenase et al., 2011) rapidly activates
hepatic iNKT cells to release IL-4, which is instrumental for B1
B-cell production of hapten-specific IgM, required for the
elicitation of CHS. A similar role of NKT cells has also been
proposed in B6 mice sensitized with Oxazolone (Nieuwenhuis
et al., 2005). Thus, it is most likely that NKT cells exert a dual
function during CHS, as they allow induction of hapten-
specific IgM early after sensitization and later on negatively
control hapten-specific CD8þ T-cell effectors. The relative
importance of these two opposite functions in CHS may
depend on the mouse strain, the nature and doses of hapten,
and sensitization protocols. It should indeed be emphasized
that the inductive role of NKT cells was documented with
a quite unusual protocol of CHS involving repeated
sensitizations at multiple sites with high doses of hapten,
whereas this study was performed with a single conventional
dose of hapten on abdominal skin. In addition, it is
noteworthy that CHS to DNFB is strongly impaired in BALB/
c mice deficient in either IL-4, B cells, or iNKT cells (Askenase
et al., 2011), whereas it normally develops in B6 mice
deficient in either B cells (mMT) (Seidel-Guyenot et al.,
2004, and data not shown) or IL-4 (Nagai et al., 2000, and
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data not shown). This indicates that NKT cells have a
prominent inductive role in CHS to DNFB in BALB/c but not
B6 mice. Whether NKT cells also display a regulatory role in
BALB/c mice and contribute to the control of the effector
phase of CHS remains to be determined.
The fact that iNKT cells regulate both the afferent and
efferent phases of CHS suggests that they may act both in LN
and in skin. However, we observed that, using CD1d-a-
GalCer tetramers, iNKT cells were virtually undetectable in
the skin before or at any time point after the hapten challenge,
a finding in agreement with another study investigating the
presence of invariant Va14Ja18 TCR transcripts (Nieuwenhuis
et al., 2005). This suggests that iNKT cells may exert their
regulatory function mainly in skin dLNs, during the hapten
presentation by the DCs. The fact that enhanced skin
inflammation was observed after immunization with hapten-
pulsed DCs from CD1d / mice as compared with DCs from
WT mice, indeed supports that iNKT cells need to interact
with DCs to exert their regulatory effects. Along these lines,
iNKT cells are activated in LN by contact with CD1dþ
epidermal Langerhans cells and mediate UV-induced
immune suppression of CHS to DNFB (Fukunaga et al.,
2010). The nature of the CD1d ligand expressed on hapten-
bearing DCs and responsible for iNKT cell activation remains
unknown. These glycolipids could be derived from
commensals or be generated endogenously in response to
the tissue stress caused by the hapten (Godfrey et al., 2004).
In this respect, iNKT stimulatory lipids rapidly accumulate in
the liver following hapten sensitization (Dey et al., 2011),
although their nature and capacity to activate NKT cells in
lymphoid organs remains elusive. Interestingly, CD1d-
dependent iNKT cell production of IL-4 and IL-13 requires
the presence of hapten-specific CD8þ T-cell effectors and of
IFN-g released by these cells. Such implication of an effector
T-cell cytokine in boosting the regulatory pathways is
reminiscent of the ability of TNF-a secreted by effector
T cells to activate suppressive Foxp3þ Treg cells controlling
diabetes (Grinberg-Bleyer et al., 2010). As IFN-g is promptly
released by CD8þ T cells during priming as well as elicitation
of CHS (Vocanson et al., 2010), the activation of iNKT cells
may take place during cognate DC/CD8 T-cell interactions
during the afferent and/or efferent phases of CHS. That IL-13
contributes to the downregulation of CHS is supported by the
enhanced skin inflammation in IL-4/IL-13 double-deficient
mice (this study), but not IL-4-deficient (Nagai et al., 2000)
(and C. Desvignes and Dominique Kaiserlian, unpublished
data) mice. However, whether iNKT cells perform their
regulatory function through IL-13, as reported earlier for
suppression of antitumor immunity (Terabe et al., 2000),
remains to be formally demonstrated.
The iNKT-mediated regulation of CHS could involve several
mechanisms. The iNKT cells might limit the differentiation of
T cells into effectors through cell contacts (Novak et al., 2005)
or alter their recruitment to the skin through cytokine
production. Indeed, IL-4 and IL-13 can inhibit CD8þ T-cell
chemotaxis to CCL5 (Tan et al., 1995), a critical chemokine for
CHS (Canavese et al., 2010). Alternatively, iNKT cells might
dampen the CD8 T-cell response indirectly by licensing LN
DCs for tolerogenic properties (Naumov et al., 2001; Diana
et al., 2011; Mattarollo et al., 2011). Finally, iNKT cells may
act through generation of Foxp3þ Tregs, which limit the
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Figure 6. Contact hypersensitivity (CHS) downregulation by invariant natural
killer T (iNKT) cell–derived cytokines induced by IFN-c from CD8þ effectors.
(a–c) IL-4 and IL-13 production by liver iNKT cells was tested in cocultures
with (a) 2,4-dinitrobenzene-sulfonic acid (DNBS)-pulsed bone marrow–derived
dendritic cells (BM-DCs) from B6 (black bars) or CD1d / (white bars) mice
with or without CD8þ effector T cells (CD8eff) and anti-CD1d mAb; (b) DNBS-
pulsed BM-DCs and CD8eff from either B6 or IL-4/IL-13
 / (4/13 / ) mice;
and (c) hapten-pulsed BM-DCs with naive (CD8N) with or without exogenous
IFN-g or effector (CD8eff) CD8
þ T cells; wt, wild type. Cytokine released in
72-hour supernatant (pool of triplicate wells) are representative of one out of
three experiments. (d) Ear swelling in IL-4/IL-13 / (IL4/13 / ; triangles) and
IL-4/IL-13þ /þ (IL4/13þ /þ ; circles) mice at 24 hours after DNFB challenge in
sensitized (white symbols) or naive (black symbols) mice. Data of individual
mice are shown. Horizontal bars indicate mean±SD of values pooled from
three experiments. **Po0.01, ****Po0.0001, Mann–Whitney U-test.
NS, nonsignificant.
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priming of hapten-specific CD8þ cytotoxic T lymphocyte in
LNs (Dubois et al., 2003; Vocanson et al., 2010) and
extravasation of CD8 effectors into the skin (Ring et al.,
2006). However, our observations (1) that iNKT cells do not
affect the proliferation, activation, and functions of Foxp3þ
Tregs in response to skin sensitization, and that (2) depletion of
either NKT cells in CD4þ T cell–deficient Ab / mice or
CD4þ T cells in NKT cell–deficient mice resulted in both cases
in exaggerated CHS responses demonstrates that CD4þ
Tregs and iNKT cells have nonredundant functions and both
control the CHS response. Finally, it would be interesting to
determine whether iNKT-mediated suppression of CHS is
triggered by type-II NKT cells, which were previously shown
to promote anergy and suppressive functions of iNKT in
various inflammatory settings (Ambrosino et al., 2007; Halder
et al., 2007).
Our data highlight the potential of iNKT cells to regulate even
established CD8þ T-cell responses involved in allergic contact
dermatitis. As new iNKT cell antigens are starting to emerge, it
will be very important to assess their therapeutic potential.
MATERIALS AND METHODS
Mice
Female C57Bl/6 mice were purchased from Charles River laboratories
(L’Arbresle, France). CD1d / and Ja18 / mice on C57BL/6
background were kindly provided by L Van Kaer (Howard Hughes
Medical Institute, Nashville, TN) and M Taniguchi (Chiba University,
Chiba, Japan), respectively, and were bred as homozygotes. IL-4/IL-
13 / mice and control IL-4/IL-13þ /þ mice on a C57Bl/6 back-
ground were obtained from A McKenzie (MRC Laboratory of
Molecular Biology, Cambridge, UK) and bred separately as homo-
zygotes. All experiments were conducted at the Plateau de Biologie
Expe´rimentale de la Souris (PBES, SFR Biosciences Gerland-Lyon Sud
UMS344/US8, France) under specific pathogen-free conditions with
mice between 2 and 4 months of age. They were conducted with the
approval of and in accordance with the guidelines for animal
experiments of the local ethics committee (CECCAPP Lyon, France).
Antibodies and flow cytometry
The following antibodies were used for flow cytometry analysis: anti-
NK1.1-PE (PK136), anti-CD8a-PE-Cy7, anti-biotin (53-6.7), anti-CD5-
RPE-Cy5.5 (53-7.3), anti-CD4-FITC (RM4-4), anti-CD45-FITC
(30F11), and anti-ICOS-biot (7E.17G9) (all from BD Biosciences, Le
Pont de claix, France). Anti-TCRab-FITC (H57-597) and CFSE were
purchased from Invitrogen (Cergy-Pontoise, France), and anti-FoxP3-
PE (FJK-16s) from eBiosciences (Clinisciences, Montrouge, France).
Allophycocyanin- mCD1d-a-GalCer tetramers were provided by the
NIH tetramer facility (Atlanta, GA). FACS analyses were performed
using a FACSCanto or LSR-II flow cytometer (BD Biosciences) and the
data analyzed using FlowJo software (Tree Star, Ashland, OR).
Contact hypersensitivity
For most experiments, CHS to DNFB (Sigma-Aldrich, St Quentin
Fallavier, France) was induced and measured as previously described
(Dubois et al., 2003). Alternatively, mice were sensitized by
subcutaneous injection of 0.5 106 BM-DCs, which were pulsed
with DNBS (Sigma-Aldrich) (Krasteva et al., 1998). Ear swelling in
unsensitized but ear-challenged mice was usually o20mm.
NKT and CD4þ T-cell depletion
NKT and CD4þ T-cell depletion were carried out, respectively, by
multiple intraperitoneal injections of 200ml of the anti-NK1.1 (clone
PK136, 1/3 dilution of ascites fluid) or anti-CD4 (clone GK1.5, 100mg
per mouse (BioXCell, West Lebanon, NH))-specific mAbs before and/
or after DNFB sensitization. Protocols routinely yielded 80% deple-
tion of NK1.1þ cells and 498% depletion of CD4þ cells (data not
shown).
FACS sorting and adoptive transfer experiments
Liver leukocytes were prepared as previously described (Goubier
et al., 2008), stained with anti-NK1.1-PE and anti-CD5-RPE-Cy5.5
mAbs, and NK1.1þCD5þ cells were sorted using a FACSVantage
cell sorter (BD Biosciences). 5 105 purified cells, which were routi-
nely 497% pure and contained 480% TCRabþ CD1d-aGalCer
tetramerþ iNKT cells, were injected intravenously into Ja18 / mice
1 day before either sensitization or challenge. Alternatively, total liver
leukocytes (2–4 106) were transferred intravenously 1 day before
the challenge.
Hapten-specific T-cell responses
The capacity of CD8þ T cells, isolated from pooled axillary
and inguinal LNs of DNFB-sensitized animals, to proliferate and
produce IFN-g in response to in vitro stimulation with DNBS-
pulsed antigen-presenting cells was determined as previously
described (Dubois et al., 2003). The frequency of hapten-specific
IFN-g-producing cells in unfractionated LN cells or purified LN
CD8þ T cells was determined by an ELISPOT assay as previously
described (Kehren et al., 1999). For suppression assays, CD8þ T cells
(5 104) from day 5 DNFB-sensitized animals were cultured
with DNBS-pulsed BM-DCs (1 104) for 3 days, in the presence
of CD4þCD25þ Tregs (1.25 104) purified from the same donors or
from naive animals, and graded numbers of FACS-sorted naive liver
NKT cells.
Coculture of iNKT cells, CD8þ T cells, and DCs
5 104 FACS-sorted liver NKT cells were cocultured with DNBS-
pulsed BM-DCs (1 104) with or without CD8þ T cells (5 104)
isolated from skin dLNs of DNFB-sensitized mice. In some experi-
ments, anti-CD1d (1B1, 10mg ml 1) or anti-IFN-g (R46A2,
10mg ml 1) neutralizing mAbs (BD Bioscience), or recombinant
IFN-g (10mg ml 1) was added to the cocultures. IL-4 and IL-13
secretions were titrated in 72-hour culture supernatants by ELISA
(R&D Systems Europe, Lille, France).
Statistics
A nonparametric Mann–Whitney test was used for the assessment of
differences between groups. Po0.05 was considered significant; NS,
nonsignificant. GraphPad Prism 5.0 software (San Diego, CA) was
used to prepare graphs and for statistical analysis.
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